Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Caspase-1136 records.
Article ID | PMID | Source | Title | Publish Year | |
---|---|---|---|---|---|
A29903 | 33296631 | Med Sci (Paris) | [Caspase inhibition: From cellular biology and thanatology to potential clinical agents]. | 2020 | Details |
A30670 | 32021639 | Nutr Metab (Lond) | Oleic acid ameliorates palmitic acid induced hepatocellular lipotoxicity by inhibition of ER stress and pyroptosis. | 2020 | Details |
A30905 | 31585800 | Mol Ther | MicroRNA 223 3p Negatively Regulates the NLRP3 Inflammasome in Acute and Chronic Liver Injury. | 2019 | Details |
A31661 | 30084831 | J Lipid Res | Oxidized linoleic acid metabolites induce liver mitochondrial dysfunction, apoptosis, and NLRP3 activation in mice. | 2018 | Details |
A32305 | 31966664 | Int J Clin Exp Pathol | Obeticholic acid improves hepatic steatosis and inflammation by inhibiting NLRP3 inflammasome activation. | 2017 | Details |
A33049 | 26791024 | Arch Dermatol Res | Hydrogen sulfide diminishes the levels of thymic stromal lymphopoietin in activated mast cells. | 2016 | Details |
A33760 | 25202950 | Zhong Nan Da Xue Xue Bao Yi Xue Ban | [Effect of free fatty acid on NALP3 inflammasome signaling pathway in THP-1 macrophages]. | 2014 | Details |
A34150 | 24312444 | PLoS One | Macrophage specific caspase-1/11 deficiency protects against cholesterol crystallization and hepatic inflammation in hyperlipidemic mice. | 2013 | Details |
A34453 | 23409132 | PLoS One | Caspase-1 as a central regulator of high fat diet-induced non-alcoholic steatohepatitis. | 2013 | Details |
A34824 | 22515414 | Nutr Metab (Lond) | Docosahexaenoic acid ameliorates palmitate-induced lipid accumulation and inflammation through repressing NLRC4 inflammasome activation in HepG2 cells. | 2012 | Details |
A34859 | 22411067 | Lab Invest | Caspase-1-mediated regulation of fibrogenesis in diet-induced steatohepatitis. | 2012 | Details |
A43660 | 31162673 | Alcohol Clin Exp Res | Chalcone Derivative L6H21 Reduces EtOH + LPS-Induced Liver Injury Through Inhibition of NLRP3 Inflammasome Activation. | 2019 | Details |
A44535 | 28314211 | Mol Immunol | The role of Kupffer cells in hepatic diseases. | 2017 | Details |
A45345 | 25104498 | Am J Physiol Gastrointest Liver Physiol | Activation of N-methyl-d-aspartate receptor downregulates inflammasome activity and liver inflammation via a β-arrestin-2 pathway. | 2014 | Details |
A45469 | 24397281 | Liver Int | Panaxatriol saponin ameliorated liver injury by acetaminophen via restoring thioredoxin-1 and pro-caspase-12. | 2014 | Details |
A46259 | 19949375 | Lab Invest | Reversibility of fibrosis, inflammation, and endoplasmic reticulum stress in the liver of rats fed a methionine-choline-deficient diet. | 2009 | Details |
A47121 | 25582105 | J Hepatol | Invariant NKT cells promote alcohol-induced steatohepatitis through interleukin-1β in mice. | 2015 | Details |
A47312 | 17616758 | Am J Clin Nutr | Role of S-adenosylmethionine, folate, and betaine in the treatment of alcoholic liver disease: summary of a symposium. | 2007 | Details |
A48640 | 32585073 | J Dig Dis | Role of NLRP3 inflammasome in liver disease. | 2020 | Details |
A48735 | 30319645 | Front Immunol | Inflammasome: A Double-Edged Sword in Liver Diseases. | 2018 | Details |
A48813 | 27660175 | J Hepatol | The inflammasome in liver disease. | 2016 | Details |
A48955 | 23266490 | J Hepatol | Therapeutic strategies in inflammasome mediated diseases of the liver. | 2012 | Details |
A49264 | 35806450 | Int J Mol Sci | The P2X7R-NLRP3 and AIM2 Inflammasome Platforms Mark the Complexity/Severity of Viral or Metabolic Liver Damage. | 2022 | Details |
A49284 | 35800450 | Front Pharmacol | Protective Effect of Danshen Zexie Decoction Against Non-Alcoholic Fatty Liver Disease Through Inhibition of ROS/NLRP3/IL-1β Pathway by Nrf2 Signaling Activation. | 2022 | Details |
A49326 | 35787975 | Cell Mol Gastroenterol Hepatol | Cell-specific deletion of NLRP3 inflammasome identifies myeloid cells as key drivers of liver inflammation and fibrosis in murine steatohepatitis. | 2022 | Details |
A49396 | 35765026 | J Transl Med | Rhubarb free anthraquinones improved mice nonalcoholic fatty liver disease by inhibiting NLRP3 inflammasome. | 2022 | Details |
A49642 | 35682887 | Int J Mol Sci | The Role of Autophagy and Pyroptosis in Liver Disorders. | 2022 | Details |
A49861 | 35616069 | Food Funct | Walnut green husk ethanol extract improves gut microbiota and their metabolites associated with NLRP3 in non-alcoholic steatohepatitis. | 2022 | Details |
A49883 | 35609854 | J Nutr Biochem | Excess fructose enhances oleatic cytotoxicity via reactive oxygen species production and causes necroptosis in hepatocytes. | 2022 | Details |
A50015 | 35563377 | Int J Mol Sci | Regulatory Roles of Caspase-11 Non-Canonical Inflammasome in Inflammatory Liver Diseases. | 2022 | Details |
A50534 | 35350750 | Front Pharmacol | The NLRP3 Inflammasome in Non-Alcoholic Fatty Liver Disease and Steatohepatitis: Therapeutic Targets and Treatment. | 2022 | Details |
A51164 | 35408890 | Int J Mol Sci | The Role of Endoplasmic Reticulum Stress and NLRP3 Inflammasome in Liver Disorders. | 2022 | Details |
A51319 | 35644437 | J Ethnopharmacol | Uncovering the mechanism of Huanglian-Wuzhuyu herb pair in treating nonalcoholic steatohepatitis based on network pharmacology and experimental validation. | 2022 | Details |
A51937 | 33078304 | Arch Pharm Res | Recent insights on modulation of inflammasomes by adipokines: a critical event for the pathogenesis of obesity and metabolism-associated diseases. | 2020 | Details |
A52085 | 31495623 | J Dairy Sci | Hepatic nuclear factor kappa B signaling pathway and NLR family pyrin domain containing 3 inflammasome is over-activated in ketotic dairy cows. | 2019 | Details |
A52337 | 28403789 | Curr Med Chem | Metaflammation: Tissue-Specific Alterations of the NLRP3 Inflammasome Platform in Metabolic Syndrome. | 2018 | Details |